PT  - JOURNAL ARTICLE
AU  - Mudit Kapoor
AU  - Shamika Ravi
AU  - A.K. Shiva Kumar
TI  - COVID 19, Consumption and Inequality: A Systematic Analysis of Rural Population of India
AID  - 10.1101/2021.06.08.21258525
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.08.21258525
4099  - http://medrxiv.org/content/early/2021/06/12/2021.06.08.21258525.short
4100  - http://medrxiv.org/content/early/2021/06/12/2021.06.08.21258525.full
AB  - Background COVID19 pandemic has had major impact on consumption levels and inequality within India. Government policy interventions have targeted poor households for cash and food transfers. It is important, however, to study the impact of the pandemic on consumption levels of non-poor in India, and in particular the middle class. In this paper, we aim to quantify the changes in consumption levels and inequality over time, across all groups of rural households in India.Methods We analyze three rounds of COVID 19-related shock surveys between May and September 2020. These surveys cover rural households of six large states in India and are representative of more than 442 million (52% of India’s rural population).Findings In the early phase of the pandemic, it was the bottom 40% of households that experienced the most severe decline in consumption. But as the pandemic deepened, consumption declined across all classes of households. Besides the poorest, it was particularly severe for the middle class (defined as 40%-80%). We also measure consumption inequality over time and find that the Gini coefficient of consumption distribution increased significantly.Interpretation In addition to focusing on poor households, policy responses to alleviate people’s sufferings would have to consider a more comprehensive boost to consumption and compensate for the reduced consumption among middle class families as well.Funding None.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIndia - COVID-19-Related Shocks in Rural India 2020, Rounds 1-3. https://microdata.worldbank.org/index.php/catalog/3830. https://microdata.worldbank.org/index.php/catalog/3830